These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10587853)

  • 1. Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs.
    Boivin S; Belicar P; Melki V
    Diabetes Care; 1999 Dec; 22(12):2089-90. PubMed ID: 10587853
    [No Abstract]   [Full Text] [Related]  

  • 2. Local adverse events associated with long-term treatment by implantable insulin pumps. The French EVADIAC Study Group experience. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Bélicar P; Lassmann-Vague V
    Diabetes Care; 1998 Feb; 21(2):325-6. PubMed ID: 9540008
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of implantable insulin pumps: the EVADIAC position. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Evaluation dans le Diabete du Traitement par Implants Actifs.
    Lassmann-Vague V; Guerci B; Hanaire-Broutin H; Pinget M; Renard E; Selam JL; Vague P
    Diabetes Metab; 1997 Jun; 23(3):234-50. PubMed ID: 9234003
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V
    Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump: the EVADIAC experience. Evaluation dans le Diabete du Traitement par Implants Actifs.
    Gin H; Melki V; Guerci B; Catargi B;
    Diabetes Care; 2001 Jan; 24(1):175. PubMed ID: 11194228
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable insulin pumps. A position statement about their clinical use.
    Renard E; Schaepelynck-Bélicar P;
    Diabetes Metab; 2007 Apr; 33(2):158-66. PubMed ID: 17300973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps. Evadiac Study Group.
    Jeandidier N; Selam JL; Renard E; Guerci B; Lassman-Vague V; Rocher L; Hanaire-Broutin H
    Diabetes Care; 1996 Jul; 19(7):780. PubMed ID: 8799645
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Das Neves Martins Pires PH; Marega A; Creagh JM
    Afr J Prim Health Care Fam Med; 2018 Oct; 10(1):e1-e6. PubMed ID: 30456971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The implantable insulin pump in the treatment of diabetes. Hopes and reality?].
    Vague P; Lassmann-Vague V; Belicar P; Alessis C
    Bull Acad Natl Med; 1996 Apr; 180(4):831-41; discussion 841-3. PubMed ID: 8925331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of implantable infusion pumps for continuous infusion of human insulin in rats: potential for group housing.
    Jensen VFH; Mølck AM; Mårtensson M; Strid MA; Chapman M; Lykkesfeldt J; Bøgh IB
    Lab Anim; 2017 Jun; 51(3):273-283. PubMed ID: 27465034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic technology assessment. Continuous peritoneal insulin infusion and implantable insulin infusion pumps for diabetic control.
    JAMA; 1989 Dec; 262(22):3195-8. PubMed ID: 2810677
    [No Abstract]   [Full Text] [Related]  

  • 12. [External and implantable insulin pumps and other techniques in insulin therapy].
    Slama G; Selam JL
    Journ Annu Diabetol Hotel Dieu; 1992; ():113-22. PubMed ID: 1495230
    [No Abstract]   [Full Text] [Related]  

  • 13. Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.
    Kropff J; Choudhary P; Neupane S; Barnard K; Bain SC; Kapitza C; Forst T; Link M; Dehennis A; DeVries JH
    Diabetes Care; 2017 Jan; 40(1):63-68. PubMed ID: 27815290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin delivery by implanted pumps: one-year trial with programmable infusion systems (the Point Study).
    Walter H
    Int J Artif Organs; 1989 Dec; 12(12):793-8. PubMed ID: 2693370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable insulin pumps: an effective option with restricted dissemination.
    Spaan NA; Teplova AE; Renard E; Spaan JA
    Lancet Diabetes Endocrinol; 2014 May; 2(5):358-60. PubMed ID: 24795244
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin pumps and glucose regulation.
    Thompson JS; Duckworth WC
    World J Surg; 2001 Apr; 25(4):523-6. PubMed ID: 11344407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effets perturbateurs endocriniens des pesticides organochlores.
    Charlier C; Plomteux G
    Acta Clin Belg; 2002; 57 Suppl 1():2-7. PubMed ID: 24862516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2009 resource guide. Insulin pumps. Some people with diabetes use wearable pumps to provide their insulin.
    Diabetes Forecast; 2009 Jan; 62(1):49-52. PubMed ID: 19445086
    [No Abstract]   [Full Text] [Related]  

  • 19. [Do implantable insulin pumps have a value other than experimental?].
    Selam JL
    Ann Med Interne (Paris); 1992; 143(1):2-4. PubMed ID: 1605456
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin therapy of diabetes with implantable infusion pumps: clinical aspects.
    Selam JL
    Int J Artif Organs; 1990 May; 13(5):261-6. PubMed ID: 2194976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.